# A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®

> **NCT00391027** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 261 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine (Lantus®)
- **DRUG:** Inhaled Human Insulin (Exubera®)

## Key facts

- **NCT ID:** NCT00391027
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391027, "A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00391027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*